NEW YORK (360Dx) – Researchers at McGill University have developed a microfluidic immunohistochemistry assay that enables multiplexed protein detection while retaining sample structural and spatial information.

The group has launched a spinout, Parallex BioAssays, to commercialize the underlying technology, which uses slides preprinted with antibodies to target proteins to enable what Huiyan Li, a postdoc in the lab of McGill professor David Juncker, said is a streamlined and inexpensive approach to multiplexed IHC.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.